Please enter url.
Login
Logout
Please enter url.
Dr Gibson on Addressing Remaining Unmet Needs in GI Cancers
onclive.com
source
Comments
Dr. Lazar on Risk Stratification for Chemotherapy and Adjuvant Therapy ...
Dr. Muss on the Use of Metronomic Chemotherapy in Metastatic Breast Cancer
Dr Falchi on the Use of Glofitamab in R/R LBCL
Dr Gulley on the Investigation of PRGN-2009 Plus Bintrafusp Alfa in HPV ...
Dr. Merchant on the Importance of Continued Care in Pediatric ...
Dr Brufsky on Unmet Needs and Unanswered Questions in HR+/HER2– Breast ...
Dr. Friedland on a Multimodal Screening Blood Test to Detect CRC
Dr. Ross on the Rise of Colon and Rectal Cancer in Young Patients
Dr Skoulidis on Determinants of KRAS G12C Inhibitor Efficacy in NSCLC
Dr. Azzi on the Rationale for the CIRCULATE Study in CRC
Dr. Catenacci on Navigating HER2 Testing in Gastric/GEJ Cancer
Dr. Morganstein on the Mechanism of Action of Lurbinectedin in ...
Dr. DeAngelo on Rates of CRS with Obe-cel in ALL
Dr. Langer on the Benefit of Atezolizumab Following Progression in ...
Dr. O’Malley on the Rationale to Evaluate Balstilimab/Zalifrelimab in ...
ASH 2019 - Page 2 of 3 - Cancer Therapy Advisor
Dr. Galsky on Developments in SOC Metastatic Urothelial Cancer Treatment
Dr. Spira on the Role of Broad Molecular Testing in Lung Cancer
Dr Siegel on the Use of Carfilzomib/Iberdomide/Dexamethasone Therapy in ...
Dr. Maron on the Role of PD-1 Inhibition in Esophagogastric Cancer
Dr Hutson on the Final OS Analysis of the CLEAR Study in Advanced RCC
Dr. Henick on Further Exploring the Immune Microenvironment in Lung Cancer
Dr Kittai on an Indirect Comparison of Acalabrutinib Plus Obinutuzumab ...
Dr Slomovitz on the Classification of Molecular Subtypes to Guide ...
Dr Shusterman on a DNA Methylome Enrichment Platform for Early ...
Dr. Porcu on the Need for Diverse Representation in Clinical Trials
Dr Zeybek on the Investigation of Neoadjuvant Olaparib in Newly ...
Dr. Walden on the RNA Expression of Homologous Recombination Genes in CRC
Dr McGregor on Next Steps For Cabozantinib Plus Atezolizumab in ...
Dr. Spira on the Results of the TROPION-PanTumor01 Trial in NSCLC
Imaging method, new medication take aim at prostate cancer | The ...
Dr. Albitar on the Importance of Obtaining Genomic Testing in Oncology
Dr McAndrew on the Implications of the PHERGain Study in HER2+ Breast ...
Dr. Hays on the Importance of Genetic Testing in Colorectal Cancer
Dr. Barata on the Challenges of Treating Advanced Urothelial Carcinoma
